Literature DB >> 6193721

Factors influencing prognosis in childhood autoimmune hemolytic anemia.

M A Heisel, J A Ortega.   

Abstract

Prognostic factors were evaluated in 25 children with autoimmune hemolytic anemia (AIHA). Patients with acute disease were generally 2-12 years of age at diagnosis, had a sudden onset of symptoms, showed low reticulocyte counts, had decreased numbers of nucleated red blood cells or early white blood cells precursors on peripheral blood smear, and had normal platelet counts. They responded well to steroids and the disease resolved within 6 months without mortality. Children with chronic AIHA were generally less than 2 or greater than 12 years of age, had a more prolonged onset of symptoms, had increased reticulocyte counts, had increased numbers of nucleated red blood cells and early white blood cell precursors on peripheral blood smear, and had decreased platelet counts. They had a variable response to steroids frequently requiring other modalities of treatments and had a mortality of 25%. Females in this group had a significant incidence of associated diseases. Autoantibodies were characterized as to temperature sensitivity and reaction with class specific antiglobulin reagents and were related to the type of AIHA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193721

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  8 in total

1.  New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Authors:  Nathalie Aladjidi; Guy Leverger; Thierry Leblanc; Marie Quitterie Picat; Gérard Michel; Yves Bertrand; Brigitte Bader-Meunier; Alain Robert; Brigitte Nelken; Virginie Gandemer; Hélène Savel; Jean Louis Stephan; Fanny Fouyssac; Julien Jeanpetit; Caroline Thomas; Pierre Rohrlich; André Baruchel; Alain Fischer; Geneviève Chêne; Y Perel
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

2.  Autoimmune Haemolytic Anaemia-A Spectrum of Presentation in Children.

Authors:  Amitabh Singh; Anirban Mandal; Ankita Patel; Sataroopa Mishra
Journal:  J Clin Diagn Res       Date:  2017-09-01

3.  Haemolysis in childhood.

Authors:  B Holland; C A Wardrop
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

4.  Cold haemagglutinin disease complicating Mycoplasma pneumoniae infection in a child under cytotoxic cancer treatment.

Authors:  F M Fink; K Dengg; S Kilga-Nogler; D Schönitzer; H Berger
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

5.  Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.

Authors:  Kunihiko Moriya; Tetsuro Matsuhashi; Masaei Onuma; Hidetaka Niizuma; Takeshi Rikiishi; Hiroshi Asada; Jun Suzuki; Yoji Sasahara; Shigeo Kure
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

6.  Autoimmune hemolytic anemia.

Authors:  V Gupta; J Shukla; B D Bhatia
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

Review 7.  The Clinical Pictures of Autoimmune Hemolytic Anemia.

Authors:  Charles H Packman
Journal:  Transfus Med Hemother       Date:  2015-09-11       Impact factor: 3.747

8.  Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case report.

Authors:  Chiara Beretta; Veronica Leoni; Mario Renato Rossi; Momcilo Jankovic; Nicolo Patroniti; Giuseppe Foti; Ettore Biagi
Journal:  J Med Case Rep       Date:  2009-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.